Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : Avxl crawled time : 12:03 save search
Anavex Life Sciences Announces Participation at Precision in Clinical Trials Virtual Summit
Published: 2021-02-19 (Crawled : 12:03) - globenewswire.com
AVXL | $3.41 -7.34% -8.24% 9
|
Health Technology
|
| O: 1.03%
H: 1.49%
C: -1.65%
life science trial anavex
Anavex Life Sciences to Present at the 10th Annual SVB Leerink Global Healthcare Conference on February 25, 2021
Published: 2021-02-18 (Crawled : 12:03) - globenewswire.com
AVXL | $3.41 -7.34% -8.24% 9
|
Health Technology
|
| O: -0.86%
H: 1.98%
C: 0.0%
life science svb leerink global anavex
Anavex Life Sciences Reports Fiscal 2021 First Quarter Financial Results And Business Outlook
Published: 2021-02-11 (Crawled : 12:03) - globenewswire.com
AVXL | $3.41 -7.34% -8.24% 9
|
Health Technology
|
| O: -5.57%
H: 5.51%
C: -1.58%
financial results results life science anavex
Anavex Life Sciences Receives Michael J. Fox Foundation Grant for Clinical Study of ANAVEX®2-73 (blarcamesine) in People with Parkinson’s Disease
Published: 2021-01-11 (Crawled : 12:03) - globenewswire.com
AVXL | $3.41 -7.34% -8.24% 9
|
Health Technology
|
| O: 1.06%
H: 0.18%
C: -1.75%
disease life science parkinson anavex®2-73 anavex
Anavex Life Sciences to Present at the H.C. Wainwright Virtual BioConnect Conference
Published: 2021-01-06 (Crawled : 12:03) - globenewswire.com
AVXL | $3.41 -7.34% -8.24% 9
|
Health Technology
|
| O: 0.0%
H: 7.74%
C: 5.61%
life science anavex
Anavex Life Sciences to Announce Fiscal 2020 Year End Financial Results December 28th, 2020
Published: 2020-12-22 (Crawled : 12:03) - globenewswire.com
AVXL | $3.41 -7.34% -8.24% 9
|
Health Technology
|
| O: 0.15%
H: 1.89%
C: -7.08%
life science results anavex
Anavex Life Sciences Announces Webinar on Rett Syndrome and ANAVEX®2-73 (Blarcamesine) Phase 2 Data hosted by Ladenburg Thalmann & Co.
Published: 2020-12-21 (Crawled : 12:03) - globenewswire.com
AVXL | $3.41 -7.34% -8.24% 9
|
Health Technology
|
| O: 0.0%
H: 9.26%
C: 7.27%
life science phase 2 anavex®2-73 anavex syndros rett syndrome
Gainers vs Losers
| 61% | 39% |
Top 10 Gainers
BOF | $2.08 77.78% 39.06% 110M
|
BHIL | $0.1793 -4.37% 19.24% 340K
|
Agriculture, Forestry, Fishing ...
UMAC | $1.48 -1.33% 14.87% 20K
|
CI | $352.28 -0.11% 13.53% 2
|
Health Services
CIG.C | $2.89 -1.37% 12.8% 2.3K
|
n/a
BMTX 4 | $1.545 0.98% 10.03% 2.5K
|
Information
TAL | $12.26 0.57% 9.22% 12M
|
Consumer Services
MTH | $154.69 -2.21% 7.56% 64
|
Consumer Durables
ASXC | $0.243 -2.41% 7.0% 1.1M
|
Manufacturing
IHT P | $1.3712 0.82% 6.48% 0
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.